AbbVie Inc logo

AbbVie Inc

31
14
NYSE:ABBV (USA)   Ordinary Shares
$ 166.35 +1.69 (+1.03%) 12:58 PM EST
60.93
P/B:
28.34
Market Cap:
$ 294.55B
Enterprise V:
$ 337.96B
Volume:
2.23M
Avg Vol (2M):
5.80M
Also Trade In:
Volume:
2.23M
Avg Vol (2M):
5.80M
Market Cap $ M 294,547.13
Enterprise Value $ M 337,955.52
P/E(ttm) 60.93
PE Ratio without NRI 18.77
Forward PE Ratio 14.93
Price/Book 28.34
Price/Sales 5.35
Price/Free Cash Flow 13.20
Price/Owner Earnings 22.74
Payout Ratio % 0.67
Revenue (TTM) $ M 54,318.00
EPS (TTM) $ 2.73
Beneish M-Score -2.87
10-y EBITDA Growth Rate % 14.70
5-y EBITDA Growth Rate % 15.50
y-y EBITDA Growth Rate % -28.80
EV-to-EBIT 39.88
EV-to-EBITDA 19.68
PEG 1.21
Shares Outstanding M 1,770.65
Net Margin (%) 8.95
Operating Margin % 24.92
Pre-tax Margin (%) 11.51
Quick Ratio 0.76
Current Ratio 0.87
ROA % (ttm) 3.58
ROE % (ttm) 36.93
ROIC % (ttm) 9.52
Dividend Yield % 3.66
Altman Z-Score 1.96
Piotroski F-Score 5.00
Positive ROA Y
Positive CFROA Y
Higher ROA y-y N
Cash flow > Earnings Y
Lower Leverage y-y Y
Higher Current Ratio y-y N
Less Shares Outstanding y-y Y
Gross Margin Increase y-y N
Higher Asset Turnover y-y N

ABBV Number of Guru Trades

To

ABBV Volume of Guru Trades

To

Gurus Latest Trades with NYSE:ABBV

No Available Data

NYSE:ABBV is held by these investors

Guru
Portfolio Date
Current Shares
% of Shares outstanding
% of Total Assets Managed
Comment
T Rowe Price Equity Income Fund 2024-03-31
515,000
0.03
0.52%
Reduce -30.87%
Robert Bruce 2023-12-31
138,000
0.01
7.58%
Reduce -15.34%
Joel Greenblatt 2023-12-31
44,417
0
0.13%
Reduce -39.64%
Ken Fisher 2023-12-31
33,909
0
0%
Reduce -8.29%
Mario Gabelli 2023-12-31
15,231
0
0.03%
Reduce -6.3%
Dodge & Cox 2023-12-31
11,006
0
0%
Reduce -1.52%
Keeley-Teton Advisors, LLC 2023-12-31
2,395
0
0.05%
Reduce -9.18%
Private Capital 2023-12-31
1,793
0
0.03%
Add 11.64%
Total 8

AbbVie Inc Insider Transactions

No Available Data

News about NYSE:ABBV

Total 0
  • 1